Sun Pharma Announces 34th AGM, Setting Record Date and Declaring Final Dividend for FY2025-26
Sun Pharmaceutical Industries Limited has scheduled its 34th Annual General Meeting and announced key details regarding the final dividend payment for the financial year 2025-26. The company set the record date and provided timelines for shareholder actions concerning the corporate events.The 34th AGM of Sun Pharmaceutical Industries Limited is slated to be held on Friday, July 31, 2026, at 4:00 p.m. (IST). The meeting will be conducted through Video Conferencing. Shareholders are advised to update their contact details with Depository Participants or the Company's Registrar and Transfer Agent (RTA) to ensure timely receipt of the AGM Notice and Annual Report.
Dividend Details and Record Date
Tuesday, July 7, 2026, has been fixed as the record date for determining which shareholders are entitled to receive the final dividend for the financial year 2025-26.The company announced a final dividend of ₹5/- (Rupees Five only) per equity share. Should this dividend be approved by the shareholders at the AGM, its payment is scheduled for on or before Friday, August 7, 2026.
Tax Deducted at Source Guidance
Regarding the dividend distribution, it is noted that the amount shall be subject to deduction of tax at source (TDS) at applicable rates. Shareholders who require specific guidance related to TDS are directed to consult the information available on the Company's official website. Requisite documentation must be submitted by Tuesday, July 7, 2026, to facilitate the correct application of the appropriate TDS rate.SUNPHARMA Stock Price Movement
As of 2:49 PM, Sun Pharmaceutical Industries Limited is edging higher in live trading, gaining 0.48% or ₹8.50 to reach ₹1794.90. The equity has seen robust activity today, with over 1.23 million shares traded during the current session.Disclaimer: Due care and diligence have been taken in compiling and presenting news and market-related content. However, errors or omissions may arise despite such efforts.
The information provided is for general informational purposes only and does not constitute investment advice, a recommendation, or an offer to buy or sell any securities. Readers are advised to rely on their own assessment and judgment and consult appropriate financial advisers, if required, before taking any investment-related decisions.
Any views, opinions, or statements expressed, where applicable, are those of the respective analysts or experts and do not reflect the views of this website. The website has no association with such viewpoints and does not assume any responsibility for them.